We are delighted to announce that GHP Healthcare & Pharmaceutical Awards recently recognised the work of Syphrama Pty Ltd with the Best Biotechnology Healthcare Products Manufacturer, Australia Award.
Elaine Chan, Syphrama CEO was also recognised at the prestigious industry awards as the Most Forward-Thinking Pharmaceutical CEO (Asia Pacific).
Medical technology, also known as ‘MedTech’, is intended to improve the quality of medical care we receive through earlier diagnosis, less invasive treatment options and reduction in hospital stays and rehabilitation times. MedTech includes and is not limited to, Medical Devices, Information Technology, Patient Portals, Implant Technology, Orthopaedics, Telemedicine and Mobile Health.
Over the past five years, Elaine has led the organisation through an enormous growth stage, doubling the size and production capabilities of the Australian based facility. In 2020 Sypharma partnered with the University of Queensland’s on their Rapid Response Vaccine Pipeline Program, managing the fill and finish of their SARS-CoV-2 Sclamp Vaccine for Phase 1 clinical trials, and are proud to contribute to the creation of products in support of healthier futures for our communities.
“I would like to thank GHP Awards for this wonderful recognition, and the board and the staff at Sypharma for their hard work and dedication in producing the ‘best biotechnology healthcare products in Australia.’ I am very proud of what the organisation has achieved in the past 5 years and for the many exciting opportunities that await the team and the industry.” Elaine Chan
For more visit: https://www.ghp-news.com/winners/sypharma-pty-ltd/